TABLE 2.

Primary and secondary outcomes.

	Desensitized group N = 14	Control group N = 42	p-value
30-day all-cause mortality	2 (14.3)	12 (28.6)	0.24
In-hospital mortality	2 (14.3)	11 (26.2)	0.30
Infection-related mortality	2 (14.3)	9 (21.4)	0.44
Clinical cure (hospital discharge)	10 (71.4)	23 (54.8)	0.22
30-day hospital readmission	5 (35.7)	7 (16.7)	0.13
Antibiotic-related adverse events	0 (0)	5 (11.9)	0.22

Data are presented as n (%), unless otherwise specified. Statistical significance at p < 0.05.